Greenlight Re Swings Back To A Profit As Underwriting Rebounds, But Solasglas Weakness And A Shrinking Open Market Book Keep The Recovery Thin

Greenlight Capital Re (NASDAQ: GLRE) returned to profitability in the third quarter, earning $0.10 per diluted share compared with a loss of $0.13 a year earlier. That swing translates to 176.9% year-over-year earnings growth. Revenue of $148.29 million rose 1.5%. The sequential improvement matters more than the year-over-year comparison: the quarter follows a second-quarter net loss of $29.6 million. The combined ratio recovered to 90.5% from 100.1% in Q2 and 96.0% in Q1. But the profit was a modest $3.2 million, and the drivers behind it lean heavily on a quiet catastrophe quarter and reserve releases rather than a clear inflection in the core book. That is the central tension.

The quality of the quarter deserves scrutiny. Underwriting income of $14.6 million was a sharp rebound from a $0.2 million loss in Q2, but it was well below the $22.3 million earned a year ago. The combined ratio was nearly four points worse than the prior year's 86.6%. CEO Greg Richardson credited a "relatively benign catastrophe and large loss environment" and favorable development on the Middle East exposures reserved conservatively last quarter. The call indicated a $6 million release against the roughly $25 million provision built through Q2. Even so, total prior-year development was 1.6 points adverse. The 1.5% revenue gain also masks the top line underneath it. Net premiums earned fell 7% to $153.4 million, and the total investment loss narrowed to $4.6 million from $17.4 million. The investment side again subtracted value. Solasglas lost $15.1 million, returning -3.3% after a -5.4% Q2. Net investment income of $10.5 million was helped by $4.1 million of realized gains on partial sales of two Innovations holdings.

Beneath the consolidated figures, the two segments are moving in opposite directions, and neither is clean.

• **Open Market:** Gross premiums written fell 10.4%, and net premiums written dropped 19% as market softening continued. That decline deepened from -10% in Q2. The segment's 87.9% combined ratio was a big improvement on Q2's 100.7% but worse than 84.5% a year ago. The acquisition cost ratio rose 4.1 points, the expense ratio rose 1.1 points, and specialty attritional losses were higher.
• **Innovations:** Gross premiums written grew 46% to $43 million, up from 12% growth in Q2 though below Q1's 73%. The expense ratio improved 2 points on scale. However, 7.6 points of adverse prior-year development pushed the segment's combined ratio to 98.2% from 89.7% in Q2, and its loss ratio rose 13.5 points.

Growth in the newer business is arriving alongside reserve questions. Meanwhile, ceded premiums nearly doubled to $39.2 million, contributing to a 12.3% decline in total net premiums written. No formal guidance changed. Management reaffirmed expectations for further Open Market premium declines and continued Innovations growth.

The forward catalysts sit largely within Innovations. A new partnership with Hippo Holdings involves co-investing in early-stage MGAs, with Spinnaker serving as preferred U.S. admitted fronting carrier. Syndicate 3456 transitions to a full syndicate on January 1, 2027. Capital return is the more tangible lever:

• Greenlight repurchased $8.0 million of stock in Q3 at $15.77 per share.
• It bought another $3.3 million in October at $14.95.
• A new repurchase agreement with David Einhorn runs through March 2027.
• Year-to-date buybacks reached roughly 5.4% of shares.

With fully diluted book value per share at $20.78, repurchases well below book are accretive, and they helped lift that figure 0.8% sequentially. On the risk side, Solasglas was flat year to date through October, down from +6.1% at the end of July and +9.8% in February. The SOFR futures macro position remains a drag, and lead director Joe Platt will retire at year-end.

The market has not rewarded the rebound. Shares at $15.09 are down 2.3% since the open following the August report and sit about 4.6% below the 200-day moving average of $15.83. The stock continues to trade at a steep discount to book. Investor sentiment, already negative, slipped modestly from -0.33 to -0.38, a softening rather than a capitulation. The Earnings Whispers trend signals are uniformly negative, with price, sequential growth, momentum and AVWAP all pointing lower. That reflects a stock that has been grinding down despite buybacks.

The bottom line is that Greenlight Re's third quarter repaired much of the damage from a loss-heavy Q2, but the repair was helped by benign catastrophes and reserve releases. Investment returns remain a headwind, Open Market premiums are shrinking faster, and Innovations' growth came with adverse development. Book value is inching higher largely through underwriting luck and accretive buybacks. Until Solasglas stabilizes and the Innovations book proves its reserving, skeptics have legitimate ammunition, and the discount to book is likely to persist.

Read our earnings preview for Greenlight Capital Re, Ltd.: https://www.earningswhispers.com/article/GLRE/21654

This earnings review was originally published on Earnings Whispers.

This article is for informational purposes only and is not investment advice. Earnings Whispers and its staff may hold positions in the securities mentioned. It is AI-assisted, based on proprietary Earnings Whispers data and company reports, and edited by Earnings Whispers staff.